The three main mechanisms of ER␣ action are: 1) nuclear, genomic, direct DNA binding, 2) nuclear, genomic, "tethered"-mediated, protein-protein interactions, and 3) non-nuclear, non-genomic, rapid action responses. Reports suggest the D-domain or hinge region of ER␣ plays an important role in mechanisms 1 and 2 above. Studies demonstrating the functionality of the ER␣ hinge region have resected the full D-domain; therefore, site directed mutations were made to attribute precise sequence functionality to this domain. This study focuses on the characterization and properties of three novel site directed ER␣-D-domain mutants. The Hinge 1 (H1) ER␣ mutant has disrupted nuclear localization, can no longer perform tethered mediated responses and has lost interaction with c-Jun, but retains estrogen response element (ERE)-mediated functions as demonstrated by confocal microscopy, reporter assays, endogenous gene expression and co-immunoprecipitation. The H2 ER␣ mutant is non-nuclear, but translocates to the nucleus with estradiol (E 2 ) treatment and maintains ERE-mediated functionality. The H2؉NES ER␣ mutant does not maintain nuclear translocation with hormone binding, no longer activates EREtarget genes, functions in ERE-or tethered-mediated luciferase assays, but does retain the non-genomic, non-nuclear, rapid action response. These studies reveal the sequence(s) in the ER␣ hinge region that are involved in tethered-mediated actions as well as nuclear localization and attribute important functionality to this region of the receptor. In addition, the properties of these ER␣ mutants will allow future studies to further dissect and characterize the three main ER␣ mechanisms of action and determine the mechanistic role each action has in estrogen hormone regulation.Many of the biological effects of estrogen are mediated through the estrogen receptors (ERs), 2 ER␣ and ER, which belong to the nuclear receptor superfamily (1). Focusing on ligand-dependent activation, to date, there are three main mechanisms of action for ER␣ that include 1) nuclear, genomic, direct DNA binding, 2) nuclear, genomic, "tethered"-mediated protein-protein interactions, and 3) non-nuclear, non-genomic, rapid action responses (2-8). Mechanism 1 involves liganded ER␣ bound to estrogen response elements (EREs) of target genes to mediate changes in gene expression via the "classical" ER␣ DNA binding responses (4, 9). The 2nd mechanism involves the recruitment and interaction of ER␣ which "tethers" to other transcription factors, such as c-Jun and Sp1, forming a protein-protein complex that interacts directly with the AP-1 and Sp1 DNA response elements, respectively (7, 10, 11). Lastly, the 3rd mechanism, involves a small population of non-nuclear ER␣ that mediates rapid signaling events which include cellular calcium mobilization, nitric oxide synthesis, and activation of intracellular signaling cascades such as those involving MAPK/ERK, Src, or Akt (5, 12).ER␣, as with all nuclear receptors, maintains the classical domain demarcations. Each domain ...